Glenmark Launches RYALTRIS Nasal Spray For Allergic Rhinitis In Brazil

Glenmark's wholly-owned subsidiary launched RYALTRIS nasal spray in Brazil for moderate-to-severe allergic rhinitis in adults and adolescents 12+ following ANVISA approval earlier this year, introducing Brazil's first olopatadine-containing intranasal combination of olopatadine and mometasone, already approved in 57 markets.